Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
RESEARCH TOOLSreports
Holding MRKR?
Track your performance easily
MRKR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.44 - $6.16
Previous Close$3.79
Volume11.81K
Average Volume (3M)35.57K
Market Cap
$33.82M
Enterprise Value$26.02M
Total Cash (Recent Filing)$7.80M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Mar 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.16
Shares Outstanding8,922,695
10 Day Avg. Volume28,777
30 Day Avg. Volume35,572
Standard Deviation0.32
R-Squared0.06
Alpha-0.00962
Financial Highlights & Ratios
Price to Book (P/B)3.48
Price to Sales (P/S)37.31
Price to Cash Flow (P/CF)-2.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.18
Enterprise Value/Gross Profit7.86
Enterprise Value/Ebitda-2.24
Forecast
1Y Price Target
$19.00Price Target Upside410.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Marker Therapeutics News
PremiumCompany Announcements
Marker Therapeutics Excels in Lymphoma Treatment Study
PremiumCompany Announcements
Marker Therapeutics Receives $2M NIH Grant for Lymphoma Study
PremiumCompany Announcements
Marker Therapeutics’ Promising Cancer Therapy Progress
PremiumCompany Announcements
Marker Therapeutics’ MT-601 Shows Promising ResultsOwnership Overview
―
Insiders
3.51% Mutual Funds
0.18% Other Institutional Investors
93.43% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
MRKR FAQ
What was Marker Therapeutics Inc’s price range in the past 12 months?
Marker Therapeutics Inc lowest stock price was $2.44 and its highest was $6.16 in the past 12 months.
What is Marker Therapeutics Inc’s market cap?
Currently, no data Available
When is Marker Therapeutics Inc’s upcoming earnings report date?
Marker Therapeutics Inc’s upcoming earnings report date is Mar 13, 2025 which is in 120 days.
How were Marker Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Marker Therapeutics Inc overvalued?
According to Wall Street analysts Marker Therapeutics Inc’s price is currently Undervalued.
Does Marker Therapeutics Inc pay dividends?
Marker Therapeutics Inc does not currently pay dividends.
What is Marker Therapeutics Inc’s EPS estimate?
Marker Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marker Therapeutics Inc have?
Marker Therapeutics Inc has 8,922,695 shares outstanding.
What happened to Marker Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Marker Therapeutics Inc?
Among the largest hedge funds holding Marker Therapeutics Inc’s share is Aisling Capital Management LP. It holds Marker Therapeutics Inc’s shares valued at 2M.
---
Marker Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
39.08%
12-Months-Change
Fundamentals
Return on Equity
-71.74%
Trailing 12-Months
Asset Growth
-46.82%
Trailing 12-Months
Company Description
Marker Therapeutics Inc
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which specializes in the development and commercialization of novel cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
---
MRKR Stock 12 Month Forecast
Average Price Target
$19.00
▲(410.75% Upside)
Technical Analysis
Best Analysts Covering MRKR
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
-2.00%
reiterated a buy rating 23 days ago
Copying Aydin Huseynov's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -2.00% per trade.
---